Company Filing History:
Years Active: 2009-2020
Title: The Innovative Contributions of Andrei Raibekas
Introduction
Andrei Raibekas is a notable inventor based in Thousand Oaks, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of methods and compositions involving IL-1ra. With a total of two patents to his name, Raibekas has demonstrated a commitment to advancing medical technology.
Latest Patents
Raibekas's latest patents include innovative methods aimed at reducing the aggregation of IL-1ra. One patent details methods of reducing aggregation by incubating IL-1ra with at least one accessory molecule. This patent also encompasses kits that include IL-1ra and at least one accessory molecule, as well as pharmaceutical compositions featuring these components. Another patent focuses on IL-1ra variants, providing for an IL-1ra with reduced aggregation and methods to achieve this reduction.
Career Highlights
Throughout his career, Andrei Raibekas has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Amgen Inc. and Swedish Orphan Biovitrum AB. His work in these organizations has contributed to the development of innovative therapeutic solutions.
Collaborations
Raibekas has collaborated with several professionals in his field, including Bruce A. Kerwin and Bruce Kerwin. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.
Conclusion
Andrei Raibekas is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to improving medical treatments.